Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supraclavicular block with bupivacaine plus dexmedetomidine vs granisetron vs magnesium sulphate in upper extremity orthopedic surgery
IRCT20141209020258N125Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in upper extremity fracture comparing Bupivacaine + dexmedetomidine, Bupivacaine + granisetron and Bupivacaine + magnesium sulphate (3 arms). Started Sep 2019; status: completed.
02
Drugs
bupivacainedexmedetomidinegranisetronmagnesium sulfate
03
Conditions
upper extremity fracture
Beyond the preview
Go deeper on IRCT20141209020258N125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N125.